Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines

Virology

Volumn 500, Issue , 2017, Pages 1-10

  Nogales, Aitor ^a   Huang, Kai ^b   Chauché, Caroline ^c   DeDiego, Marta L ^a,d   Murcia, Pablo R ^c   Parrish, Colin R ^b   Martínez Sobrido, Luis ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Cornell University ^*  (United States)

^c MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

^d UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Canine influenza virus; Canine tracheal explant; Inactivated influenza vaccines; Influenza A virus; Live attenuated influenza vaccines; Non structural protein 1; NS1 deficient influenza viruses; Reverse genetics

Indexed keywords

INFLUENZA VACCINE; KENNEL COUGH VACCINE; NONSTRUCTURAL PROTEIN 1; INS1 PROTEIN, INFLUENZA VIRUS; LIVE VACCINE; VIRAL PROTEIN; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANINE INFLUENZA VIRUS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOGENICITY; INFLUENZA A; INFLUENZA A VIRUS (H3N8); INFLUENZA VACCINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; TRACHEA; VIRUS RECOMBINANT; VIRUS REPLICATION; ANIMAL; C57BL MOUSE; DOG; DOG DISEASES; GENETICS; IMMUNOLOGY; ORTHOMYXOVIRIDAE INFECTIONS; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; DOG DISEASES; DOGS; FEMALE; HUMANS; INFLUENZA A VIRUS, H3N8 SUBTYPE; INFLUENZA VACCINES; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; VACCINES, ATTENUATED; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84991832955     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2016.10.008     Document Type: Article

References (59)

1. Anderson, T.C., Crawford, P.C., Dubovi, E.J., Gibbs, E.P., Hernandez, J.A., Prevalence of and exposure factors for seropositivity to H3N8 canine influenza virus in dogs with influenza-like illness in the United States. J. Am. Vet. Med. Assoc. 242 (2013), 209–216.
2. Baskin, C.R., Bielefeldt-Ohmann, H., Garcia-Sastre, A., Tumpey, T.M., Van Hoeven, N., Carter, V.S., Thomas, M.J., Proll, S., Solorzano, A., Billharz, R., Fornek, J.L., Thomas, S., Chen, C.H., Clark, E.A., Murali-Krishna, K., Katze, M.G., Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus. J. Virol. 81 (2007), 11817–11827.
3. Bean, W.J., Schell, M., Katz, J., Kawaoka, Y., Naeve, C., Gorman, O., Webster, R.G., Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts. J. Virol. 66 (1992), 1129–1138.
4. Belshe, R.B., Edwards, K.M., Vesikari, T., Black, S.V., Walker, R.E., Hultquist, M., Kemble, G., Connor, E.M., Group, C.-T.C.E.S., Live attenuated versus inactivated influenza vaccine in infants and young children. N. Engl. J. Med 356 (2007), 685–696.
5. Belshe, R.B., Gruber, W.C., Mendelman, P.M., Mehta, H.B., Mahmood, K., Reisinger, K., Treanor, J., Zangwill, K., Hayden, F.G., Bernstein, D.I., Kotloff, K., King, J., Piedra, P.A., Block, S.L., Yan, L., Wolff, M., Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J. Infect. Dis. 181 (2000), 1133–1137.
6. Bush, R.M., Fitch, W.M., Bender, C.A., Cox, N.J., Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol. Biol. Evol. 16 (1999), 1457–1465.
7. Centers, 2010. Licensure of a high-dose inactivated influenza vaccine for persons aged ≥65 years (Fluzone High-Dose) and guidance for use – United States, 2010, MMWR Morb Mortal Wkly Rep, 2010/05/01 ed, vol. 59, pp. 485–486.
8. Choi, E.H., Song, M.S., Park, S.J., Pascua, P.N., Baek, Y.H., Kwon, H.I., Kim, E.H., Kim, S., Jang, H.K., Poo, H., Kim, C.J., Choi, Y.K., Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene. Arch. Virol. 160 (2015), 1729–1740.
9. Cox, A., BakerS.F., NogalesA., Martinez-SobridoL., DewhurstS., 2014. Development of a mouse-adapted, live-attenuated influenza virus that permits in vivo analysis of enhancements to the safety of LAIV. J Virol.
10. Crawford, P.C., Dubovi, E.J., Castleman, W.L., Stephenson, I., Gibbs, E.P., Chen, L., Smith, C., Hill, R.C., Ferro, P., Pompey, J., Bright, R.A., Medina, M.J., Johnson, C.M., Olsen, C.W., Cox, N.J., Klimov, A.I., Katz, J.M., Donis, R.O., Transmission of equine influenza virus to dogs. Science 310 (2005), 482–485.
11. Deshpande, M.S., Jirjis, F.F., Tubbs, A.L., Jayappa, H., Sweeney, D., Spencer, S.J., Lakshmanan, N., Wasmoen, T.L., Evaluation of the efficacy of a canine influenza virus (H3N8) vaccine in dogs following experimental challenge. Vet. Ther. 10 (2009), 103–112.
12. Dundon, W.G., De Benedictis, P., Viale, E., Capua, I., Serologic evidence of pandemic (H1N1) 2009 infection in dogs, Italy. Emerg. Infect. Dis. 16 (2010), 2019–2021.
13. Falcon, A.M., Fernandez-Sesma, A., Nakaya, Y., Moran, T.M., Ortin, J., Garcia-Sastre, A., Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins. J. Gen. Virol. 86 (2005), 2817–2821.
14. Feng, K.H., Gonzalez, G., Deng, L., Yu, H., Tse, V.L., Huang, L., Huang, K., Wasik, B.R., Zhou, B., Wentworth, D.E., Holmes, E.C., Chen, X., Varki, A., Murcia, P.R., Parrish, C.R., Equine and canine influenza H3N8 viruses show minimal biological differences despite phylogenetic divergence. J. Virol. 89 (2015), 6860–6873.
15. Ferko, B., Stasakova, J., Romanova, J., Kittel, C., Sereinig, S., Katinger, H., Egorov, A., Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J. Virol. 78 (2004), 13037–13045.
16. Garcia-Sastre, A., Egorov, A., Matassov, D., Brandt, S., Levy, D.E., Durbin, J.E., Palese, P., Muster, T., Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252 (1998), 324–330.
17. Geiss, G.K., Salvatore, M., Tumpey, T.M., Carter, V.S., Wang, X., Basler, C.F., Taubenberger, J.K., Bumgarner, R.E., Palese, P., Katze, M.G., Garcia-Sastre, A., Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc. Natl. Acad. Sci. USA 99 (2002), 10736–10741.
18. Gonzalez, G., Marshall, J.F., Morrell, J., Robb, D., McCauley, J.W., Perez, D.R., Parrish, C.R., Murcia, P.R., Infection and pathogenesis of canine, equine, and human influenza viruses in canine tracheas. J. Virol. 88 (2014), 9208–9219.
19. Hai, R., Martinez-Sobrido, L., Fraser, K.A., Ayllon, J., Garcia-Sastre, A., Palese, P., Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach. J. Virol. 82 (2008), 10580–10590.
20. Hale, B.G., Randall, R.E., Ortin, J., Jackson, D., The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89 (2008), 2359–2376.
21. Hayward, J.J., Dubovi, E.J., Scarlett, J.M., Janeczko, S., Holmes, E.C., Parrish, C.R., Microevolution of canine influenza virus in shelters and its molecular epidemiology in the United States. J. Virol. 84 (2010), 12636–12645.
22. Hoelzer, K., Murcia, P.R., Baillie, G.J., Wood, J.L., Metzger, S.M., Osterrieder, N., Dubovi, E.J., Holmes, E.C., Parrish, C.R., Intrahost evolutionary dynamics of canine influenza virus in naive and partially immune dogs. J. Virol. 84 (2010), 5329–5335.
23. Holt, D.E., Mover, M.R., Brown, D.C., Serologic prevalence of antibodies against canine influenza virus (H3N8) in dogs in a metropolitan animal shelter. J. Am. Vet. Med. Assoc. 237 (2010), 71–73.
24. Hussain, A.I., Cordeiro, M., Sevilla, E., Liu, J., Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells. Vaccine 28 (2010), 3848–3855.
25. de Jong, J.C., Smith, D.J., Lapedes, A.S., Donatelli, I., Campitelli, L., Barigazzi, G., Van Reeth, K., Jones, T.C., Rimmelzwaan, G.F., Osterhaus, A.D., Fouchier, R.A., Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe. J. Virol. 81 (2007), 4315–4322.
26. Kohlmeier, J.E., Woodland, D.L., Immunity to respiratory viruses. Annu. Rev. Immunol. 27 (2009), 61–82.
27. Lamb, R.A., Choppin, P.W., Chanock, R.M., Lai, C.J., Mapping of the two overlapping genes for polypeptides NS1 and NS2 on RNA segment 8 of influenza virus genome. Proc. Natl. Acad. Sci. USA 77 (1980), 1857–1861.
28. Larson, L.J., Henningson, J., Sharp, P., Thiel, B., Deshpande, M.S., Davis, T., Jayappa, H., Wasmoen, T., Lakshmanan, N., Schultz, R.D., Efficacy of the canine influenza virus H3N8 vaccine to decrease severity of clinical disease after cochallenge with canine influenza virus and Streptococcus equi subsp. zooepidemicus. Clin. Vaccin. Immunol. 18 (2011), 559–564.
29. Martinez-Sobrido, L., Garcia-Sastre, A., Generation of recombinant influenza virus from plasmid DNA. J. Vis. Exp., 2010.
30. Martinez-Sobrido, L., Zuniga, E.I., Rosario, D., Garcia-Sastre, A., de la Torre, J.C., Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 80 (2006), 9192–9199.
31. Martinez-Sobrido, L., Emonet, S., Giannakas, P., Cubitt, B., Garcia-Sastre, A., de la Torre, J.C., Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 83 (2009), 11330–11340.
32. Nogales, A., DeDiego, M.L., Topham, D.J., Martinez-Sobrido, L., Rearrangement of influenza virus spliced segments for the development of live-attenuated vaccines. J. Virol. 90 (2016), 6291–6302.
33. Nogales, A., Baker, S.F., Ortiz-Riano, E., Dewhurst, S., Topham, D.J., Martinez-Sobrido, L., Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development. J. Virol. 88 (2014), 10525–10540.
34. Outbreak, of canine influenza caused by new strain of virus. J. Am. Vet. Med. Assoc., 246, 2015, 1049.
35. Park, M.S., Shaw, M.L., Munoz-Jordan, J., Cros, J.F., Nakaya, T., Bouvier, N., Palese, P., Garcia-Sastre, A., Basler, C.F., Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J. Virol. 77 (2003), 1501–1511.
36. Parrish, C.R., Kawaoka, Y., The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu. Rev. Microbiol. 59 (2005), 553–586.
37. Parrish, C.R., Murcia, P.R., Holmes, E.C., Influenza virus reservoirs and intermediate hosts: dogs, horses, and new possibilities for influenza virus exposure of humans. J. Virol. 89 (2015), 2990–2994.
38. Pecoraro, H.L., Spindel, M.E., Bennett, S., Lunn, K.F., Landolt, G.A., Evaluation of virus isolation, one-step real-time reverse transcription polymerase chain reaction assay, and two rapid influenza diagnostic tests for detecting canine Influenza A virus H3N8 shedding in dogs. J. Vet. Diagn. Investig. 25 (2013), 402–406.
39. Pica, N., Palese, P., Toward a universal influenza virus vaccine: prospects and challenges. Annu. Rev. Med. 64 (2013), 189–202.
40. Pica, N., Langlois, R.A., Krammer, F., Margine, I., Palese, P., NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge. J. Virol. 86 (2012), 10293–10301.
41. Quinlivan, M., Zamarin, D., Garcia-Sastre, A., Cullinane, A., Chambers, T., Palese, P., Attenuation of equine influenza viruses through truncations of the NS1 protein. J. Virol. 79 (2005), 8431–8439.
42. Ramirez-Martinez, L.A., Contreras-Luna, M., De la Luz, J., Manjarrez, M.E., Rosete, D.P., Rivera-Benitez, J.F., Saavedra-Montanez, M., Ramirez-Mendoza, H., Evidence of transmission and risk factors for influenza A virus in household dogs and their owners. Influenza Other Respir. Virus. 7 (2013), 1292–1296.
43. Randall, R.E., Goodbourn, S., Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89 (2008), 1–47.
44. Richt, J.A., Garcia-Sastre, A., Attenuated influenza virus vaccines with modified NS1 proteins. Curr. Top. Microbiol. Immunol. 333 (2009), 177–195.
45. Richt, J.A., Lekcharoensuk, P., Lager, K.M., Vincent, A.L., Loiacono, C.M., Janke, B.H., Wu, W.H., Yoon, K.J., Webby, R.J., Solorzano, A., Garcia-Sastre, A., Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine. J. Virol. 80 (2006), 11009–11018.
46. Rimmelzwaan, G.F., Fouchier, R.A., Osterhaus, A.D., Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development. Curr. Opin. Biotechnol. 18 (2007), 529–536.
47. Smith, G.J., Vijaykrishna, D., Bahl, J., Lycett, S.J., Worobey, M., Pybus, O.G., Ma, S.K., Cheung, C.L., Raghwani, J., Bhatt, S., Peiris, J.S., Guan, Y., Rambaut, A., Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459 (2009), 1122–1125.
48. Solorzano, A., Webby, R.J., Lager, K.M., Janke, B.H., Garcia-Sastre, A., Richt, J.A., Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J. Virol. 79 (2005), 7535–7543.
49. Song, D., Kang, B., Lee, C., Jung, K., Ha, G., Kang, D., Park, S., Park, B., Oh, J., Transmission of avian influenza virus (H3N2) to dogs. Emerg. Infect. Dis. 14 (2008), 741–746.
50. Song, D., Kim, H., Na, W., Hong, M., Park, S.J., Moon, H., Kang, B., Lyoo, K.S., Yeom, M., Jeong, D.G., An, D.J., Kim, J.K., Canine susceptibility to human influenza viruses (A/pdm 09H1N1, A/H3N2 and B). J. Gen. Virol. 96 (2015), 254–258.
51. Steel, J., Lowen, A.C., Pena, L., Angel, M., Solorzano, A., Albrecht, R., Perez, D.R., Garcia-Sastre, A., Palese, P., Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J. Virol. 83 (2009), 1742–1753.
52. Steidle, S., Martinez-Sobrido, L., Mordstein, M., Lienenklaus, S., Garcia-Sastre, A., Staheli, P., Kochs, G., Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response. J. Virol. 84 (2010), 12761–12770.
53. Talon, J., Salvatore, M., O'Neill, R.E., Nakaya, Y., Zheng, H., Muster, T., Garcia-Sastre, A., Palese, P., Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc. Natl. Acad. Sci. USA 97 (2000), 4309–4314.
54. Taubenberger, J.K., Kash, J.C., Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 7 (2010), 440–451.
55. Vincent, A.L., Ma, W., Lager, K.M., Janke, B.H., Webby, R.J., Garcia-Sastre, A., Richt, J.A., Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vaccine 25 (2007), 7999–8009.
56. Wang, L., Suarez, D.L., Pantin-Jackwood, M., Mibayashi, M., Garcia-Sastre, A., Saif, Y.M., Lee, C.W., Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry. Vaccine 26 (2008), 3580–3586.
57. Webster, R.G., Bean, W.J., Gorman, O.T., Chambers, T.M., Kawaoka, Y., Evolution and ecology of influenza A viruses. Microbiol Rev. 56 (1992), 152–179.
58. Yoon, K.J., Cooper, V.L., Schwartz, K.J., Harmon, K.M., Kim, W.I., Janke, B.H., Strohbehn, J., Butts, D., Troutman, J., Influenza virus infection in racing greyhounds. Emerg. Infect. Dis. 11 (2005), 1974–1976.
59. Yoon, S.W., Webby, R.J., Webster, R.G., Evolution and ecology of influenza a viruses. Curr. Top. Microbiol. Immunol. 385 (2014), 359–375.